摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-氯甲基-5-叔丁基呋喃-2-羧酸甲酯 | 701216-59-3

中文名称
4-氯甲基-5-叔丁基呋喃-2-羧酸甲酯
中文别名
——
英文名称
methyl 4-chloromethyl-5-tert-butylfuran-2-carboxylate
英文别名
methyl 5-tert-butyl-4-chloromethyl-furan-2-carboxylate;methyl 5-tert-butyl-4-chlormethyl-furan-2-carboxylate;Methyl 5-tert-butyl-4-(chloromethyl)furan-2-carboxylate
4-氯甲基-5-叔丁基呋喃-2-羧酸甲酯化学式
CAS
701216-59-3
化学式
C11H15ClO3
mdl
——
分子量
230.691
InChiKey
WVSONEWTFMTQOA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    140-142 °C(Press: 2 Torr)
  • 密度:
    1.128±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    39.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-氯甲基-5-叔丁基呋喃-2-羧酸甲酯氢氧化钾氯化亚砜溶剂黄146 作用下, 以 为溶剂, 反应 26.0h, 生成 4-chloromethyl-5-tert-butylfuran-2-diethylcarboxamide
    参考文献:
    名称:
    3- and 4-Dialkoxyphosphorylmethyl Derivatives of 5-tert-Butylfuran with Electron-Withdrawing Substituents in Position 2
    摘要:
    A procedure for preparing 3- and 4-halomethyl derivatives of 5-tert-butylfuran containing electron-withdrawing substituents in position 2 was developed, and phosphorylation of the resulting products under the conditions of the Arbuzov and Michaelis-Becker reactions was studied. 3-Bromomethyl derivatives are phosphorylated with trimethyl phosphite considerably faster than their 4-chloromethyl analogs. At the same time, 3- and 4- chloromethyl derivatives of N,N-diethyl-5-tert-butylfuran-2-carboxamide under the conditions of the Michaelis-Becker reaction only slightly differ in chemical properties.
    DOI:
    10.1023/b:rugc.0000018647.14195.32
  • 作为产物:
    描述:
    2-糠酸甲酯盐酸 、 aluminum (III) chloride 、 zinc(II) chloride 作用下, 以 二硫化碳四氯化碳乙醚 为溶剂, 反应 102.0h, 生成 4-氯甲基-5-叔丁基呋喃-2-羧酸甲酯
    参考文献:
    名称:
    [EN] PYRIDYLTRIAZOLES
    [FR] PYRIDYLTRIAZOLES
    摘要:
    本发明涵盖了一般式(1)中的化合物,其中基团R0至R3和L的定义如索赔1中所述,适用于治疗以细胞过度或异常增殖为特征的疾病,包括含有这种化合物的药物制剂以及它们作为药物的用途。
    公开号:
    WO2011117382A1
点击查看最新优质反应信息

文献信息

  • [EN] PYRIDYLTRIAZOLES<br/>[FR] PYRIDYLTRIAZOLES
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2011117382A1
    公开(公告)日:2011-09-29
    The present invention encompasses compounds of general formula (1) wherein the groups R0 to R3 and L are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.
    本发明涵盖了一般式(1)中的化合物,其中基团R0至R3和L的定义如索赔1中所述,适用于治疗以细胞过度或异常增殖为特征的疾病,包括含有这种化合物的药物制剂以及它们作为药物的用途。
  • B-RAF KINASE INHIBITORS
    申请人:Steurer Steffen
    公开号:US20130190286A1
    公开(公告)日:2013-07-25
    The present invention encompasses compounds of general formula (1) where in the groups R 0 to R 3 and L are defined as in claim 1 , which are suitable for the 5 treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain compounds of this kind and their use as medicaments.
    本发明涵盖了通式(1)的化合物,其中R0到R3和L的定义如权利要求1所述,适用于治疗由过度或异常细胞增殖所特征的疾病,包含这种化合物的制药制剂以及它们作为药物的使用。
  • PYRIDYLTRIAZOLES
    申请人:Ettmayer Peter
    公开号:US20130225562A1
    公开(公告)日:2013-08-29
    The present invention encompasses compounds of general formula (1) wherein the groups R 0 to R 3 and L are defined as in claim 1 , which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.
    本发明涵盖通式(1)的化合物,其中R0至R3和L基团的定义如权利要求1所述,适用于治疗由过度或异常细胞增殖特征的疾病,包含这种化合物的制药制剂以及它们作为药物的用途。
  • Synthesis and Phosphorylation of 2-, 3-, and 4-Halomethyl-5-tert-butylfurans
    作者:L. M. Pevzner
    DOI:10.1023/b:rugc.0000031868.97123.e1
    日期:2004.4
    Synthetic methods for preparing of 2-, 3-, and 4-halomethyl-5-tert-butylfurans are developed. It was established that the bromination of 3- and 4-methyl-2-tert-butylfurans with N-bromosuccinimide proceeds mainly at the free alpha-position of the furan ring, and not at the methyl group. Therefore, the target halomethylfurans were prepared through the corresponding 3- and 4-methoxymethyl derivatives. The obtained five products were phosphorylated with sodium diethyl phosphite under the conditions of the Michaelis-Becker reaction to give the corresponding phosphonates.
  • Reactions of alkyl (halomethyl)furancarboxylates with hexamethylenetetramine
    作者:I. M. Lapina、L. M. Pevzner、A. A. Potekhin
    DOI:10.1134/s1070363206080251
    日期:2006.8
    All isomers of (aminomethyl)furancarboxylic acids were prepared by the Delepine reaction from alkyl (halomethyl)furancarboxylates. Treatment of the initially formed quaternary salt with an ethanolic HCl solution yielded the salts of the corresponding unstable amino acid esters. A procedure for their purification to a high degree of purity was developed. Hydrolysis of the crude esters yielded stable amino acid salts.
查看更多

同类化合物

除草醚 醋糠硫胺 醋呋三嗪 酪氨酰-甘氨酰-色氨酰-蛋氨酰-门冬氨酰-苯基丙氨酰-甘氨酸 糠酸(呋喃甲酸) 糠酸異戊酯 糠酸烯丙酯 碘化溴刚 硫代糠酸甲酯 硝基呋喃杂质 硝呋隆 硝呋醛肟标准品 硝呋美隆 硝呋维啶 硝呋立宗 硝呋甲醚 硝呋烯腙盐酸盐 硝呋烯腙 硝呋替莫 硝呋拉定 硝呋太尔杂质B 硝呋噻唑 硝呋乙宗 盐酸呋喃它酮 盐酸呋喃他酮 甲基7-[5-乙酰氨基-4-[(2-溴-4,6-二硝基苯基)偶氮]-2-甲氧苯基]-3-羰基-2,4,10-三氧杂-7-氮杂十一烷-11-酸酯 甲基5-溴-3-甲基-2-糠酸酯 甲基5-乙酰氨基-2-糠酸酯 甲基5-{[(氯乙酰基)氨基]甲基}-2-糠酸酯 甲基5-(甲氧基甲基)-2-甲基呋喃-3-羧酸酯 甲基5-(溴甲基)-4-(氯甲基)-2-糠酸酯 甲基5-(乙氧基甲基)-2-甲基-3-糠酸酯 甲基5-({[5-(三氟甲基)-2-吡啶基]硫代}甲基)-2-糠酸 甲基5-(4-甲酰基苯基)-2-糠酸酯 甲基5-(3-甲酰基苯基)-2-糠酸酯 甲基4-甲基-3-糠酸酯 甲基4-溴-5-甲基-2-糠酸酯 甲基4-乙酰基-5-甲基-2-糠酸酯 甲基4,6-二氯-3-(二乙基氨基)呋喃并[3,4-c]吡啶-1-羧酸酯 甲基3-羟基呋喃并[3,2-b]吡啶-2-羧酸酯 甲基3-甲酰基-2-糠酸酯 甲基3-氨基呋喃并[2,3-b]吡啶-2-羧酸酯 甲基3-氨基-5-(2-甲基-2-丙基)-2-糠酸酯 甲基3-乙基-4-苯基-2-糠酸酯 甲基3-(叔丁氧基羰基)呋喃-2-羧酸甲酯 甲基2-甲氧基-5-苯基-3-糠酸酯 甲基2-乙基-3-糠酸酯 甲基(2Z)-2-呋喃-2-基-3-(5-硝基呋喃-2-基)丙-2-烯酸酯 甲基(2E)-3-[5-(氯甲酰基)-2-呋喃基]丙烯酸酯 环己基呋喃-2-羧酸酯